Home/Filings/4/0001127602-24-016803
4//SEC Filing

Simon, Christopher 4

Accession 0001127602-24-016803

CIK 0000313143other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 5:31 PM ET

Size

6.8 KB

Accession

0001127602-24-016803

Insider Transaction Report

Form 4
Period: 2024-05-28
Simon, Christopher
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2024-05-28$95.73/sh41,736$3,995,387329,361 total
  • Award

    Common Stock

    2024-05-28+106,062371,097 total
Footnotes (3)
  • [F1]Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 18, 2021, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 18, 2021 to May 17, 2024, as certified by the Compensation Committee of the Board of Directors on May 26, 2024.
  • [F2]This number includes unvested restricted stock units ("RSUs") previously reported.
  • [F3]Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001674993

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:31 PM ET
Size
6.8 KB